Morphine and HIV‐Tat increase microglial‐free radical production and oxidative stress: possible role in cytokine regulation
Open Access
- 4 December 2008
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 108 (1), 202-215
- https://doi.org/10.1111/j.1471-4159.2008.05756.x
Abstract
Opiate abuse alters the progression of human immunodeficiency virus and may increase the risk of neuroAIDS. As neuroAIDS is associated with altered microglial reactivity, the combined effects of human immunodeficiency virus‐Tat and morphine were determined in cultured microglia. Specifically, experiments determined the effects of Tat and morphine on microglial‐free radical production and oxidative stress, and on cytokine release. Data show that combined Tat and morphine cause early and synergistic increases in reactive oxygen species, with concomitant increases in protein oxidation. Furthermore, combined Tat and morphine, but not Tat or morphine alone, cause reversible decreases in proteasome activity. The effects of morphine on free radical production and oxidative stress are prevented by pre‐treatment with naloxone, illustrating the important role of opioid receptor activation in these phenomena. While Tat is well known to induce cytokine release from cultured microglia, morphine decreases Tat‐induced release of the cytokines tumor necrosis factor‐α and interleukin‐6, as well as the chemokine monocyte chemoattractant protein‐1 (MCP‐1). Finally, experiments using the reversible proteasome inhibitor MG115 show that temporary, non‐cytotoxic decreases in proteasome activity increase protein oxidation and decrease tumor necrosis factor‐α, interleukin‐6, and MCP‐1 release from microglia. Taken together, these data suggest that oxidative stress and proteasome inhibition may be involved in the immunomodulatory properties of opioid receptor activation in microglia.Keywords
This publication has 113 references indexed in Scilit:
- Morphine Induces Ubiquitin-Proteasome Activity and Glutamate Transporter DegradationOnline Journal of Public Health Informatics, 2008
- MG132 proteasome inhibitor modulates proinflammatory cytokines production and expression of their receptors in U937 cells: involvement of nuclear factor-κB and activator protein-1Immunology, 2008
- Cell‐specific actions of HIV‐Tat and morphine on opioid receptor expression in gliaJournal of Neuroscience Research, 2008
- Glutamate release from activated microglia requires the oxidative burst and lipid peroxidationJournal of Neurochemistry, 2007
- An in Vitro Model of Morphine Withdrawal Manifests the Enhancing Effect on Human Immunodeficiency Virus Infection of Human T Lymphocytes through the Induction of Substance PThe American Journal of Pathology, 2006
- Measuring reactive species and oxidative damagein vivoand in cell culture: how should you do it and what do the results mean?British Journal of Pharmacology, 2004
- Human immunodeficiency virus‐1 Tat protein interacts with distinct proteasomal α and β subunitsFEBS Letters, 2003
- The RTP Site Shared by the HIV-1 Tat Protein and the 11S Regulator Subunit α is Crucial for their Effects on Proteasome Function Including Antigen ProcessingJournal of Molecular Biology, 2002
- Selective proteasome inhibitors as anti-inflammatory agentsExpert Opinion on Investigational Drugs, 1999
- Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophagesLife Sciences, 1993